Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-02-19 @ 5:33 PM
Study NCT ID:
NCT02392793
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2015-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies
Sponsor:
St. Jude Children's Research Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BMNIRN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None